Nature Biotechnology
23, 1050 - 1053 (2005)
doi:10.1038/nbt0905-1050
Overhauling oversight—European drug legislationLincoln Tsang
Lincoln Tsang is a member of the Pharmaceutical and Medical Devices Regulatory Practice of Arnold & Porter LLP, based in Tower 42, 25 Old Broad Street, London EC2N 1HQ, UK. lincoln_tsang@aporter.com
At the end of next month, the European Medicines Agency (EMEA) will implement a new legislative framework and several provisions that seek to provide incentives and streamline regulatory oversight of certain monoclonal antibodies and other biologic products.
|
